Cargando…
Urothelial carcinoma of donor origin in a kidney transplant patient
BACKGROUND: Malignancy after transplantation is an uncommon multifactorial occurrence. Immunosuppression to prevent graft rejection is described as a major risk factor in malignancy development in the post-transplant state. Donor-derived malignancy is a rare reported complication. Herein, we review...
Autores principales: | Michel Ortega, Rosa M., Wolff, Daynna J., Schandl, Cynthia A., Drabkin, Harry A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067888/ https://www.ncbi.nlm.nih.gov/pubmed/27777772 http://dx.doi.org/10.1186/s40425-016-0167-4 |
Ejemplares similares
-
Donor-Derived Urothelial Carcinoma in Renal Transplant Recipients
por: Qian, Zhiyu, et al.
Publicado: (2022) -
Metastatic Urothelial Carcinoma from Transplanted Kidney with Complete Response to an Immune Checkpoint Inhibitor
por: Chiang, Ryan S., et al.
Publicado: (2020) -
High-grade urothelial carcinoma in a kidney transplant recipient with BK virus infection
por: Hill, Prue, et al.
Publicado: (2009) -
Müllerian-Type Clear Cell Carcinoma of Donor Origin in a Male Patient with a Kidney Transplant: Ascertained by Molecular Testing
por: Iorgulescu, J. Bryan, et al.
Publicado: (2023) -
Urothelial Carcinoma in an Allograft kidney
por: Hejlesen, Maria Baand, et al.
Publicado: (2022)